Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NSC 31150
Cat. No.:
0225LY-0925
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
NSC 31150 is a potential PPAR agonist that could be utilized in the study of bacterial infections and cancer due to its antioxidant, antidiabetic, and antibacterial activities.
Synonym:
51244-45-2; 5-(2,4-dichlorobenzylidene)-1,3-thiazolidine-2,4-dione; 5-[(2,4-dichlorophenyl)methylidene]-1,3-thiazolidine-2,4-dione
CAS No.:
51244-45-2
Compound CID:
233068
Formula:
C10H5Cl2NO2S
Formula Weight:
274.12
Specification
Relative Density:
1.622 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
NSC 31150 can be used in medicinal chemistry to explore its biological activity across various therapeutic screening models.
Library Information
Target:
PPAR
Receptor:
PPAR
Pathways:
DNA damage/DNA repair; Oxidation-reduction; Metabolism; Microbiology/Virology
Plate Number:
AOCL-12
Plate Location:
h6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
